8
Oct
2024

Innoxel Lifesciences Private Limited

Exhibitor at CPHI Milan 2024 stand 10F63, Finished Dosage Formulations
About Us

Innoxel is an emerging CDMO based in India specialising in aseptic production of Injectable vials, Pre-filled syringes and oral liquids. Innoxel has two separate manufacturing areas, General block and Potent (Oncology) block.Innoxel was incorporated in 2020 as a green field site and will be fully operational by August 2023. The first set of product...

  • IN
  • 2023
    On CPHI since
  • 100 - 249
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 10F63, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Liposome based injectables

    Product Liposome based injectables

    Liposome based products require SKID based manufacturing, a capability not many organisations possess for the US markets. We can manufacture the same under General category of products.
  • XR oral liquids

    Product XR oral liquids

    Extended release oral liquids. Complex NDDS. For general as well as Onco based products.